Biopeak raises $2.7 million follow-on funding led by NKSquared
The clinic business plans to expand diagnostics, software and clinical programmes.
Biopeak announced a $2.7 million follow-on investment on 29 January 2026, led by NKSquared, the investment vehicle of Nikhil Kamath. The financing supports expansion of the company’s preventive-care clinic model.
The company plans to open a second clinic and invest in diagnostics, proprietary AI tools, research and clinical programmes. It also intends to recruit for its clinical, research, product and operations teams.
Founded by Rishi Pardal and Shiva Subramanian, Biopeak combines specialist consultations, diagnostic testing and ongoing monitoring. Its model brings health information and follow-up into coordinated programmes, rather than treating assessments as isolated appointments.
Use of funds
Clinic expansion
Diagnostics and software
Research and clinical teams